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Network-Level Changes in Expression
of Inducible Fos–Jun Proteins in the Striatum
during Chronic Cocaine Treatment and Withdrawal
Rosario Moratalla,* Bulent Elibol,* Mario Vallejo,† 1995). This change in behavior can last for months or
longer. At the cellular level, chronic treatment with theseand Ann M. Graybiel*
*Department of Brain and Cognitive Sciences stimulants produces increased activity in the D1-class
dopamine receptor transduction pathway involvingMassachusetts Institute of Technology
Cambridge, Massachusetts 02139 activation of the cyclic AMP (cAMP)-dependent protein
kinase (PKA) cascade with subsequent activation of†Reproductive Endocrine Unit
Massachusetts General Hospital the cAMP response element–binding protein (CREB)
through phosphorylation at Ser-133 (Cole et al., 1995;Harvard Medical School
Boston, Massachusetts 02114 Self and Nestler, 1995). Other receptors have been impli-
cated as well, including dopamine D2-class receptors
(Ruskin and Marshall, 1994), serotonin (Bhat and Bara-
ban, 1993), and glutamate NMDA receptors (Torres andSummary
Rivier, 1993; Wang et al., 1994). Changes in level of
expression of several immediate-early genes have alsoRepeated exposures to psychomotor stimulants pro-
been noted (Hope et al., 1994; Rosen et al., 1994).duce long-term changes in behavior ranging from ad-
Many of the molecules so far associated with thediction to behavioral sensitization. Many of these be-
striatal plasticity induced by psychomotor stimulantshaviorsdepend on the nigrostriatal system of thebasal
have also been implicated in neuroplasticity and long-ganglia. We show here that chronic cocaine exposure
term memory in other systems across a range of verte-not only leads to time-varying alterations in the induc-
brates and invertebrates (Bear and Malenka,1994; Frankibility of bZIP transcription factors in individual striatal
and Greenberg, 1994; Bartsch et al., 1995; Huang andneurons, but also to long-lasting network changes in
Kandel, 1995; Yin et al., 1995). However, it is still notwhich ensembles of striatal neurons express these
clear how these common mechanisms are selectivelyproteins. These network-level adaptations suggest
engaged by different neural circuits to bring about ap-that the behavioral sensitization induced by repeated
propriate adaptive responses.psychomotor stimulant exposure may reflect an en-
The striking changes in behavior associated with be-during functional reorganization of basal ganglia cir-
havioral sensitization suggested that the phenomenoncuits.
might reflect a change in the circuit-level activity of the
basal ganglia. In the experiments described here, we
asked whether one could obtain anatomical correlatesIntroduction
of such a circuit-level change by tracking changes in
the expression of immediate-early genes in the striatumIncreasing evidence suggests that mesostriatal dopa-
of rats developing behavioral sensitization. Our findingsmine systems are involved in behavioral learning as well
demonstrate that during chronic treatment with cocaineas in the expression of learned behavioral routines. The
and during drug withdrawal, Fos–Jun family proteinsmesolimbic system, which projects from the ventral teg-
undergo coordinate network-level changes in expres-mental area to the nucleus accumbens, has been impli-
sion that occur with the known time course of behavioralcated in reinforcement-based behaviors and addiction
sensitization. These findings suggest that the neuronal(Self and Nestler, 1995; Wise, 1996). The nigrostriatal
plasticity underlying behavioral sensitization may in-system is also involved in reward-based sensory-motor
volve functional reorganization of basal ganglia circuits.conditioning and motor responsiveness to addictive
drugs (Robinson and Becker, 1986; Kalivas and Stewart,
1991; Graybiel, 1995). Work in the monkey has further Results
suggested that sensory-motor conditioning may involve
changes in the relative responsiveness of neurons in the Striatal Expression of Immunodetectable
c-Fos, JunB, and FRAs Stimulatedtwo major neurochemical compartments of thestriatum,
the striosomes and the matrix (Aosaki et al., 1995). by Acute Cocaine Treatment
To obtain baseline data for the experiments on the ef-To approach the mechanismsunderlying such plastic-
ity, research in rodents has focused on studying the fects of chronic cocaine exposure, we treated rats
acutely with cocaine (25 mg/kg) and after 2 or 18 hrmolecular changes that occur when animals are treated
chronically with psychomotor stimulants. These drugs processed their brains for immunocytochemistry. Fol-
lowing a single dose of cocaine, there was a rapidincrease extracellular dopamine and other monoamines
in the striatum by blocking the dopamine transporter increase in neuronal expression of c-Fos, JunB, and
Fos-related antigen (FRA) immunoreactivities in the cau-(the main effect of cocaine) and by increasing dopamine/
monoamine release (a main effect of amphetamine) (see doputamen above control levels (Figures 1A and 1B).
The acute induction patterns for c-Fos, JunB, and FRAGiros et al., 1996). Behaviorally, chronic exposure to
psychomotor stimulants produces augmented motor re- differed in their intensities and kinetics (Figure 1A).
The intensities followed the order c-Fos < JunB < FRA.sponses to further exposure to the stimulants, a phe-
nomenon called behavioral sensitization (Robinson and The c-Fos and JunB immunoreactivities rapidly disap-
peared, but immunoreactivity detected with the FRA MBecker, 1986; Kalivas and Stewart, 1991; Cador et al.,
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Figure 1. Acute Exposure to Psychomotor Stimulants Induces Different Quantitative Levels of Fos–Jun Protein Expression in the Striatum, in
Distribution Patterns Specific to the Psychomotor Stimulant
(A) Numbers of nuclei immunopositive for c-Fos (Fos), JunB, or FRA (Fra) counted in sections from the brains of rats treated with a single
dose of cocaine (25 mg/kg, closed bars) or saline (open bars), 2 hr before perfusion (n 5 4–5 per group). Values shown are means 6 SEMs.
(B and C) Distributions of JunB-positive nuclei induced in the rat caudoputamen by acute cocaine (25 mg/kg) (B) and acute amphetamine (5
mg/kg) (C). Note the widespread distribution of JunB-positive nuclei induced in the central caudoputamen after acute cocaine (B), as compared
to the clustered striosomal distribution after acute amphetamine treatment (C). Asterisk in (C) indicates one such striosomal cluster. Charts
in (B) and (C) and in subsequent figures are prints from high contrast photographic negatives.
peptide antiserum was present at levels above baseline cocaine challenge on day 5 were markedly reduced rela-
tive to the numbers of immunoreactive striatal neuronsfor at least 18 hr (see Figures 4D and 5A). The long-
lasting FRA immunoreactivity was nuclear and confined detected following a single acute dose of cocaine (Fig-
ure 2). The numbers of JunB-positive and FRA-positiveto neurons, as were the c-Fos-, JunB-, and FRA-like
immunoreactivities detected 2 hr after stimulation. nuclei were not appreciably changed. By day 8, the
inducibility of c-Fos-like immunoreactivity was almostWe used the regional patterns of distribution of the
induced proteins as an assay to determine which striatal completely lost (z92% decrease) and the number of
JunB-positive nuclei was reduced by over half (z53%),neurons were activated by thecocaine treatment (Figure
1B). We tested for the selectivity of these cocaine- but the number of FRA-positive nuclei was nearly un-
changed (z8% lower). Thus, the latency and degree ofevoked patterns by comparing them with those found
in rats given acute amphetamine (Figure 1C), which in- response of the three protein classes, as measured by
immunostained nuclei expressing them, differed sharplyduces a different pattern of expression. We found that
the increases in expression for all three protein immuno- during chronic treatment.
reactivities occurred in the drug-specific patterns char-
acterized previously for c-fos and NGFI-A mRNAs (Gray-
Changes in the Compartmental Patterns ofbiel et al., 1990; Moratalla et al., 1992, 1993). Acute
Expression of Fos–Jun Family Proteins intreatment with cocaine induced extensive, relatively ho-
the Caudoputamen Following Chronicmogeneous expression, with strong immunolabeling in
Exposure to Cocainethe central and middle parts of the caudoputamen and
Despite the distinctly different changes in inducibility ofweak labeling laterally (Figure 1B). By contrast, acute
c-Fos-, JunB-, and FRA-like proteins that occurred withtreatment with amphetamine (5 mg/kg) led to expression
chronic cocaine treatment, all three classes of proteinin a striosome-predominant pattern in the rostral and
underwent coordinate changes in their anatomical ex-lateral caudoputamen (Figure 1C). This documentation
pression patterns in the striatum. The most striking find-of similar drug-specific patterns of induction for the
ing was a shift in distribution of immunostained cellsthree protein immunoreactivities proved to be critical
from the broad distribution characteristic of typicalfor the analysis of their patterns of expression following
acute cocaine cases (Figures 2B and 2C) to a morechronic treatment with cocaine.
patchy distribution (Figures 2B9 and 2C9).
We compared these altered distributions to the
locations of the striosome and matrix compartments ofInducibility of Immunodetectable c-Fos, JunB,
and FRAs in the Caudoputamen during and the striatum by analysis with calbindin D28K as a marker
for the matrix compartment and dynorphin as a markerafter Chronic Cocaine Treatment
To study the dynamic regulation of c-Fos, JunB, and for striosomes. These comparisons (Figures 3A–3B9)
showed that the changes in expression pattern withFRAs by chronic exposure tococaine, we gave repeated
25 mg/kg doses twice daily for 7 days, and on the next chronic cocaine treatment involved a decrease of induc-
tion in the matrix relative to nearby striosomes and anday (18 hr later) gave a single dose of cocaine followed
by a 2 hr survival time. To test for early changes in the increase of induction in striosomes.
The altered pattern of expression following chronicinducibility of the three protein immunoreactivities, we
challenged other rats on day 5. cocaine treatment and challenge was remarkably similar
to the pattern found after acute amphetamine treatmentThe numbers of c-Fos-positive nuclei found 2 hr after
Cocaine-Induced Network Changes in Fos–Jun Expression
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Figure 2. Changes in the Distribution and Levels of Expression of Fos–Jun Proteins Occur during Chronic Treatment with Cocaine
(A) Numbers of nuclei immunopositive for c-Fos (Fos), JunB, and FRA (Fra) during (day 5) and after (day 8) chronic cocaine treatment compared
to the numbers induced by acute cocaine (day 0). Values indicate means 6 SEMs (n 5 4–6) and are shown as percents of the corresponding
immunopositive nuclei found in acutely treated rats.
(B–C9) Charts illustrating the distribution of JunB-positive nuclei. (B and B9) and FRA-positive nuclei (C and C9). (B) and (C) show sections
from rats given acute cocaine (25 mg/kg) following 7 days of treatment with saline. (B9) and (C9) illustrate sections from rats given the same
dose of cocaine following 7 days of treatment with cocaine. Note change from relatively homogeneous pattern of induction in acutely treated
rats (B and C) to patchy patterns of expression of JunB and FRA with chronic cocaine treatment (B’ and C’). All rats were perfused 2 hr after
the last dose of cocaine.
(cf. Figure 1C with Figures 2B9 and 2C9). The increased regulation of c-Fos-like immunoreactivity, and the per-
sistent expression of FRA-like proteins during chronicrelative expression in striosomes was strongest in the
anterior and lateral parts of the caudoputamen, and aug- cocaine treatment and withdrawal may be indicative of
striatal neuroplasticity occurring during the course ofmented patchiness was never pronounced medially. The
pattern shift was already visible on challenge on day 5 behavioral sensitization. To test this hypothesis, we
treated a group of rats chronically with cocaine for 7in the sections immunostained for JunB and for FRAs
(data not shown). For the severely down-regulated days, allowed withdrawal periods of 18 hr or 3, 7, or 14
days, and then gave a final challenge with cocaine 2 hrc-Fos-like immunoreactivity, the patchy pattern was
also evident on challenge on day 5, but only scattered before sacrifice. Control rats were chronically treated
with saline and given cocaine challenge at the samec-Fos-positive nuclei remained by the end of the chronic
treatment (data not shown). timepoints. Qualitatively, the rats treated chronically
with cocaine, but not the control rats, showed aug-These results demonstrate that after repeated expo-
sure to cocaine, a single further dose of the same drug mented behavioral responsiveness to the drug chal-
lenge during withdrawal.activates different populations of neurons in thestriatum
than activated by cocaine in drug-naive controls. Thus, In the caudoputamen, immunoreactive c-Fos, which
had become refractory to induction by cocaine 18 hrthe pattern of induction of Fos–Jun proteins by cocaine
that has been repeatedly demonstrated for acute co- after chronic treatment, responded to the challenge
dose at roughly 60% of the acute level of response bycaine treatment is not a fixed property of the striatal
response to the drug, but changes with repeated drug 3 days of withdrawal and reached only z70% of acute
levels of inducibility after 2 weeks (Figure 4A). The num-exposure.
bers of JunB-positive nuclei present after cocaine chal-
lenge, depressed by about 50% at the end of treatment,Long-Term Effects of Chronic Cocaine Treatment
on the Inducibility and Distributions of Fos–Jun showed steady recovery during withdrawal and reached
values slightly above those of the acutely treated con-Family Proteins in the Caudoputamen
The observed redistribution of c-Fos-, JunB-, and FRA- trols by 2 weeks (Figure 4A). The numbers of FRA-posi-
tive nuclei, the least reduced by the chronic treatment,immunoreactive neurons, the nearly complete down-
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Figure 3. Chronic Cocaine Treatment Results in Long-Lasting Redistribution of Inducible Fos–Jun Protein Expression and Augmented Dynor-
phin Expression in Striosomes
(A–B9) Clusters of FRA-positive (A) and JunB-positive (B) nuclei in lateral caudoputamen of rats chronically treated with cocaine, matching
dynorphin-positive (A9) and calbindin D28K-negative (B9) striosomes in serially adjacent sections. Rats were given cocaine (25 mg/kg, b.i.d.) for
7 days and perfused 18 hr after the last cocaine injection (A and A9) or were then withdrawn from cocaine for 1 week and challenged with a
dose of cocaine (25 mg/kg) and perfused 2 hr later (B, B9, and D–G). In (A)–(B9), asterisks indicate examples of corresponding clusters.
(C and C’) Dynorphin-positive cell clusters in the caudoputamen of a rat treated with saline for 2 weeks (C) and a rat treated with cocaine (25
mg/kg, b.i.d.) for 2 weeks and perfused 2 hr after the last injection (C9). Note the greater intensity of the dynorphin immunostaining in neurons
of the chronically treated rat. Scale bars indicate 200 mm in (A9) and (B9) and 100 mm in (C9).
(D)–(F) document coordinate expression of c-Fos (D), JunB (E), and FRA (F) immunoreactivities (brown nuclei) in dynorphin-positive projection
neurons (black). Examples of doubly labeled neurons are shown at arrows. Examples of dynorphin-immunoreactive neurons without such
nuclear immunostaining are shown at small arrowheads. (G) illustrates three NADPH diaphorase-stained neurons (blue) with FRA-positive
nuclei (brown). Scale bar for (D)–(G) (in [G]) indicates 20 mm.
fell slightly until after 1 week of withdrawal, and then c-Fos as soon as appreciable numbers of c-Fos-immu-
nopositive nuclei became detectable on subsequentrose rapidly to slightly above control values at 2 weeks
(Figure 4A). challenge during withdrawal (3 days). For all three
classes of protein, the change in pattern of expres-Strikingly, the distribution of immunoreactive neurons
induced by cocaine challenge during the withdrawal pe- sion, once initiated by the chronic treatment, persisted
throughout the entire 2 week withdrawal period (Figuresriod continued to exhibit the pattern of augmented strio-
somal expression and decreased matrix expression that 4B–4C9). Thus, even when the counts of immunopositive
neurons had recovered to levels near or above thosehad developed during chronic treatment (Figures 3B,
3B9, 4B9, and 4C9). This patchy pattern was evident at found on acute treatment (as found for JunB and FRA),
or had at least undergone partial recovery (as found forthe earliest timepoints during withdrawal for JunB- and
FRA-positive nuclei (data not shown). The new pattern c-Fos), the distributions of the immunopositive neurons
remained changed. The appearance of the patternbecame evident even for the severely down-regulated
Cocaine-Induced Network Changes in Fos–Jun Expression
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Figure 4. Inducibility of Fos–JunProteins and Persistence of FRAProteins in Striatal NeuronsUndergo Time-Varying Changes during Withdrawal
from Chronic Cocaine Treatment
(A) Numbers of c-Fos-, JunB-, and FRA-immunoreactive neurons in the caudoputamen of rats given a cocaine challenge (25 mg/kg) 18 hr or
3, 7, or 14 days after withdrawal from chronic cocaine treatment (25 mg/kg, b.i.d., for 7 days). Values are plotted as a percent of those in
acutely treated rats (n 5 4–6 per group).
(B–C9) Charts comparing the distributions of JunB-positive nuclei (B and B9) and FRA-positive nuclei (C and C9) in the caudoputamen of rats
given acute cocaine (B and C) or a challenge of cocaine (25 mg/kg) given after 2 weeks of withdrawal (B9 and C9). Note that the patchy
distribution of the immunoreactive nuclei in the cocaine-treated animals persists through the full 2 week period of withdrawal.
(D) Quantitative data showing that persistent FRA-like immunoreactivity is detectable by immunohistochemical analysis for up to 1 week of
withdrawal. Bars indicate numbers of immunopositive nuclei/mm2 counted in samples from different treatment groups (n 5 4–6 per group).
Rats were injected with cocaine (25 mg/kg, b.i.d.) for 7 days and were perfused without challenge 18 hr or 3, 7, or 14 days after the last
cocaine injection. Control rats received saline injections for 7 days and were perfused 18 hr later. An asterisk indicates values different from
saline-treated control values at p < 0.05; a double dagger indicates values different from acute cocaine 18 hr treatment group values at p <
0.01. Statistics by two-tailed t tests.
change immediately after the chronic treatment (JunB treatment (Figure 4D). By day 3 of withdrawal, the num-
bers of FRA-positive neurons were reduced by aboutand FRA) and its continuation throughout thewithdrawal
(Fos, JunB, and FRA) suggest a time course paralleling 50%. They remained practically unaltered at day 7 and
then returned to control levels by day 14.that of behavioral sensitization rather than that of aug-
mented intrastriatal dopamine levels, which have been There was clearly augmented striosomal expression
of the persistent FRAs, especially in lateral striosomesshown not to appear until roughly day 3 of withdrawal
in a similar experimental protocol (Kalivas and Duffy, at the 18 hr survival times, when enough FRA-positive
nuclei were still present to score the pattern (Figures1993).
3A and 3A9). This result suggests that both persistent
FRAs and transient FRAs were subject to compartment-Persistence of FRA but Not c-Fos or JunB
Immunoreactivities in Striatal Neurons selective regulation as a result of the cocaine treatment.
Following Chronic Cocaine Treatment
Studies with the FRA antiserum we used have shown
that chronic cocaine treatment induces FRA proteins Phenotypes of Neurons Expressing c-Fos, JunB,
and FRA Immunoreactivities Following Chronicwith long half-lives (Hope et al., 1994; Zhang et al., 1992;
Rosen et al., 1994; Nye et al., 1995). To test for such a Exposure to Psychomotor Stimulants
Acute treatments with cocaine and amphetamine inducebuild-up, we treated rats with cocaine for 7 days and
analyzed the immunoreactivities detectable 18 hr later c-Fos-like immunoreactivity in a restricted subset of
neurons in the caudoputamen. These are the dynorphin-or after 3, 7, and 14 days of withdrawal with no further
challenge. There was no increase in the numbers of positive projection neurons that give rise to the “direct
pathway” of the basal ganglia (mostly matrix neurons)c-Fos-positive or JunB-positive neurons above back-
ground counts at the 18 hr timepoint or later (data not and to the pathway from striosomes to the region of the
substantia nigra, pars compacta (Berretta et al., 1992;shown). By contrast, there were large numbers of FRA-
positive neurons 18 hr after the end of the 7 day chronic Cenci et al., 1992; Johansson et al., 1994). Almost no
Neuron
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striatal interneurons show such an induction. To deter-
mine whether there was a change in this phenotypic
profile following chronic cocaine exposure, we carried
out double staining for these proteins and major pheno-
typic markers of striatal projection neurons and in-
terneurons. We chose the timepoint of 1 week with-
drawal following 7 day chronic cocaine treatment for
quantitative comparisons with acutely treated controls,
but also sampled other timepoints.
We found no major change in the phenotype of projec-
tion neurons expressing c-Fos-, JunB-, and FRA-like
immunoreactivities. All were colocalized with dynorphin
Figure 5. Western Immunoblots (FRA M Peptide Antiserum) of Cau-immunoreactivity (Figures3D–3F). There were only small
doputamen Tissue Extracts Obtained from Saline-Treated Controlnumbers of doubly labeled enkephalinergic projection
Rats (Sal) or Cocaine-Treated Rats (C)
neurons, and these declined with chronic treatment.
Cocaine (25 mg/kg intraperitoneal) was administered as acute treat-
By contrast, there were prominent changes in induc- ment (C2 or C18) or chronic (CC2 or CC18) treatments. Striatal
ibility of Fos–Jun proteins in striatal interneurons ex- extracts were prepared either 2 or 18 hr after the last dose of cocaine
pressing nitric oxide synthase (NOS). The numbers of was given. All experiments were repeated at least four times. Arrows
indicate 55 kDa (1), 45 kDa (2), and 40 kDa (3) bands, as well as aNOS-positive neurons expressing c-Fos-like and JunB-
32–37 kDa cluster of bands (4).like immunoreactivities roughly doubled (241% for
c-Fos, 189% for JunB, relative to numbers in acutely
treated rats). With FRA immunostaining (Figure 3G), we
and 3C9). Thus, changes in neuropeptide expressionfound a 407% increase in NOS-positive neurons ex-
occurred in the same groups and phenotype of projec-hibiting intense FRA-like immunoreactivity. Increases
tion neuron as the changes in Fos–Jun family proteins.(174%) were also found for persistently expressed FRAs
in rats treated chronically and then maintained for 1
Western Blotting Analysis of the Effects of Acuteweek of withdrawal without further challenge. There
and Chronic Treatment on the Expressionwere no changes for the other classes of interneuron
of Fos–FRA Proteins in the Striatumtested.
To make a direct comparison between immunohisto-These results suggest that the network-level shift in
chemical and immunoblotting results with the M peptidepatterns of inducibility of Fos–Jun proteins following
FRA antiserum, we carried out parallel immunoblottingchronic cocaine treatment are accompanied by shifts
experiments with whole-cell protein extracts from thein expression in local circuit neurons within the striatum
striatum of rats treated acutely or chronically with co-and that persistent FRAs follow the same shifts.
caine or saline.
Three series of bands were induced by acute cocaine
treatment at 2 hr survival times, the largest of whichExtended Cocaine Exposure Induces a
(z55 kDa) may represent c-Fos (Figures 5A and 5B,Continued Pattern Shift in Fos–Jun Family
band 1). This band had completely disappeared by 18Proteins and Increased Expression
hr (Figure 5A). A second cluster of bands, at 40–45 kDa,of Dynorphin in Striosomes
showed elevated intensity 2 hr after acute cocaine (Fig-To determine whether more extensive exposure to co-
ures 5A and 5B, bands 2 and 3), but had significantlycaine might fully down-regulate the inducibility of JunB
decreased by 18 hr (Figure 5A, bands 2 and 3). The 40and FRAs in the striatum, we exposed a group of rats
kDa protein remained elevated above control levels atto 2 weeks of the standard cocaine regimen (25 mg/kg,
18 hr (Figure 5A, band 3). A third cluster of cocaine-b.i.d.) and challenged the rats with a final dose of co-
induced bands was detected migrating in the 32–37 kDacaine 18 hr later. Even with this doubling of the length
range (Figures 5A and 5B, band 4). Following 1 week ofof exposure, JunB-like and FRA-like immunoreactivites
chronic cocaine treatment, these bands were also visi-were still inducible, and the shift toward striosome pre-
ble 2 hr after a cocaine challenge, but the 55 and 45dominance was still present. c-Fos-like immunoreactiv-
kDa bands were weaker than those observed in acutelyity remained almost undetectable. These results indicate
treated rats (Figure 5B). By contrast, there was strongthat the differential effects of chronic cocaine treatment
induction of the 40 and 32–37 kDa bands (Figure 5B),on c-Fos-, JunB-, and FRA-like proteins were not pecu-
which remained elevated relative to controls at 18 hrliar to the 4 day or 1 week treatment protocols, but
(Figures 5A and 5B).reflected a condition that holds even for longer periods
of time.
Earlier work has shown that chronic treatment with Discussion
cocaine increases the striatal expression of prodynor-
phin mRNA and dynorphin-like immunoreactivity (Si- Our findings suggest that at least three types of alter-
ation occur in the striatum as a result of chronic expo-vam, 1989; Smiley et al., 1990; Steiner and Gerfen, 1995),
particularly in striosomes (Daunais and McGinty, 1995). sure to cocaine: changes in the levels of expression of
inducible transcription factors available for activatingWe found an obvious increase in striosomal expression
of dynorphin-like immunoreactivity throughout most of protein 1 (AP-1) binding within striatal neurons, changes
in the inducibility of these transcription factors by athe striatum in the rats treated for 2 weeks (Figures 3C
Cocaine-Induced Network Changes in Fos–Jun Expression
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subsequent challenge with cocaine, and changes in the may constitute a different group of persistently ex-
pressed FRAs.neural circuits that express these proteins on cocaine
challenge. Remarkably, although many of the quantita-
tive changes reverted toward control levels during the Chronic Cocaine Treatment Induces Network-Level
withdrawal period following drug treatment, the net- Changes in Inducibility and Expression of bZIP
work-level changes, like the behavioral sensitization in- Proteins in the Striatum
duced by chronic treatment, did not. We suggest that Although our Western immunoblots and quantitative im-
these network-level changes reflect long-term modifica- munohistochemical analyses showed net increases or
tions in the functional reactivity of basal ganglia circuits decreases in levels of expression of Fos–Jun family pro-
and that the changes may contribute to the expression teins, the distribution analysis suggests that both local
of behavioral sensitization. increases and local decreases occurred for each protein
class depending on the ensemble of striatal neurons
examined. There was a clear down-regulation of induc-A Dynamic Transcription Factor Dimerization
ibility in parts of the matrix compartment and, in theCode May Be Induced by Chronic
same brains, an up-regulation of inducibility in parts ofCocaine Treatment
the striosomal compartment. Thus, our findings suggestAn important feature of our immunohistochemical analy-
that a consistent, long-lasting change in the compart-sis was that we could identify the phenotypes of striatal
mental expression patterns of induced and persistentneurons expressing the different protein immunoreactiv-
striatal Fos–Jun proteins is a key feature of the striatalities. The phenotypic profile suggested that the expres-
response to chronic cocaine treatment.sion of the three protein immunoreactivities largely oc-
The change in distribution pattern was already detect-curred in overlapping populations of neurons. It is thus
able after 4 days of cocaine treatment, and it persistedhighly likely that psychomotor stimulant exposure re-
after cessation of treatment for the full 2 week with-sults in changes in expression of the different AP-1 pro-
drawal period we analyzed. This time course closelyteins within single neurons of these classes. This is a
matches that of behavioral sensitization observed in acritical point, because it suggests that changes in dimer-
similar protocol by Kalivas and Duffy (1993) and notedization patterns of these proteins can occur in response
qualitatively by ourselves. The distribution change ap-to the chronic treatment. Such different heterodimeric
peared to be a property of the compartment phenotypecomplexes could, in turn, recognize different variants of
per se. The change was qualitatively similar for all theAP-1 and CRE regulatory sites located in the promoter
protein immunoreactivities we studied, despite the factregions of target genes and lead to changes in their
that individual protein species differed sharply fromtranscriptional regulation.
each other in the quantitative aspects of their regulation.Our findings further indicate that there is not one
Even the severely down-regulated c-Fos-like immunore-change in AP-1-binding proteins available for potential
activity, when it became inducible again during with-dimerizationbut rather,a complexand continually evolv-
drawal, showed the ensemble shift toward striosomeing group of changes in these proteins and their expres-
predominance. The pattern change was evident also forsion patterns, both during drug treatment and during
FRAs expressed persistently in the absence of furtherwithdrawal. This temporal variation suggests that differ-
challenge.ent networks of target genes may be hierarchically acti-
These ensemble-level alterations were associatedvated and/or repressed during chronic cocaine treat-
with two clear changes at the single-neuron level. First,ment and withdrawal in a time-dependent manner. Such
dynorphin-positive projection neurons were affected,time-varying combinations of regulatory events could
some being recruited toexpress these proteins (neuronsultimately be responsible for progressive and long-
of some striosomes), others (neurons in parts of thelasting changes in neuronal organization induced by the
matrix) becoming refractory to the induction of detect-drug treatment. Interestingly, however, none of the
able levels of the Fos–Jun proteins. Second, there waschanges in level of expression followed the known time
a marked recruitment of NOS-containing interneurons.course of behavioral sensitization, which begins soon
This result is particularly interesting because these neu-after initiation of treatment and persists through with-
rons are local network inhibitory interneurons that havedrawal periods even longer than the 2 week period we
matrix-predominant distributions, tend to lie at strio-chose (Kalivas and Duffy, 1993).
some–matrix borders, and are thought to generate feed-In agreement with Hope et al. (1994), Rosen et al.
forward inhibition to the matrix compartment (Kawa-(1994), and Nye et al. (1995), we found that chronic co-
guchi et al., 1995). Thus, they potentially could generatecaine treatment induced major alterations in the compo-
part or all of the down-regulation in the matrix, whichsition of the protein bands detected with the FRA antise-
contributed to the general ensemble shift in expressionrum, some of which may correspond to previously
that we found.identified “chronic FRAs” (Hope et al., 1994; Nye et al.,
1995). However, we were consistently able to detect the
induction of 32–37 kDa FRAs even after acute cocaine Altered Dopamine Receptor Signaling and
Receptor Interactions May Be Involved in thetreatment and could not find convincing evidence for
the existence of 32–37 kDa FRAs specifically induced Regulatory Changes in bZIP Protein Expression
The molecular mechanisms by which chronic cocaineby chronic, but not by acute, cocaine treatment (Hope
et al., 1994; Nye et al., 1995). The bands we detected treatment recruits striosomal neurons and removes ma-
trix neurons from the pool of responsive striatal neuronsin the 40–50 kDa range, and especially the 40 kDa band,
Neuron
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are unknown. One obvious possibility is that, following sensitized animal. This correlation is interesting from
the behavioral point of view, because the known proper-chronic cocaine treatment, the relative efficacy of the
D1-class dopamine receptor pathway is augmented in ties of the striosomal compartment of the striatum make
it plausible that augmented activation of striosomalstriosomes but is reduced in the matrix. An interesting
alternative possibility is that the ensemble-level change functions might play a part in the stereotyped behaviors
typical of the sensitized animal. Relative to the matrixreflects an altered balance of D1-class and D2-class
dopamine receptor function in the striatum. The one of the caudoputamen, striosomes have preferred con-
nectivity with key elements of the limbic forebrain, in-other situation in which a noncompartmental pattern of
striatal immediate-early gene induction has been experi- cluding cortical regions that, in the human, have been
implicated in the altered metabolic activity associatedmentally converted into a patchy, striosome-predomi-
nant pattern is when D1-class and D2-class agonist with abnormal repetitive behavioral patterns (reviewed
by Eblen and Graybiel, 1995).treatments have been combined (Paul et al., 1992; La-
Hoste et al., 1993; Wirtshafter and Asin, 1994; see also
Zhang et al., 1992; Dilts et al., 1993). The pattern evoked
Experimental Proceduresby combined D1–D2-class dopamine receptor agonists
in normal rats is similar to that seen in rats treated with
Adult male Sprague–Dawley rats (Charles River Labs, Wilmington,acute amphetamine and, as we show here, to that
MA) initially weighing 180–200 g were housed in pairs at the MIT
seen when the patterns induced by acute cocaine be- animal facility under a 12 hr light/dark cycle with free access to food
come transformed to a striosome-enhanced pattern and water.
Rats were treated with intraperitoneal injections of cocaine HClwith chronic cocaine treatment. Interestingly, rats given
(25 mg/kg, Sigma, St. Louis, MO) twice a day for 4, 7, or 14 days.D1- and D2-class agonists in combination show en-
The rats received either no challenge or a challenge dose of cocainehanced behavioral stereotypy, as do rats sensitized by
18 hr after the last administration and were euthanized 2 or 18 hrchronic exposure to cocaine. Such a shift in D1–D2 bal-
later. To analyze the effects of drug withdrawal, rats were treated for
ance could be precipitated by different relative changes 7 days with cocaine as described above and were given withdrawal
in dopamine release and/or reuptake (Robinson and periods of 18 hr or 3, 7, or 14 days with a final cocaine challenge
before euthanasia 2 or 18 hr later. Some rats received an intraperito-Becker, 1986; Kalivas and Stewart, 1991).
neal injection of saline or no treatment in place of the cocaine chal-
lenge. Control rats were treated with two daily intraperitoneal injec-
tions of saline and a final cocaine or saline challenge. Other ratsThe Changes in Transcription Factor Expression
were treated acutely with cocaine (25 mg/kg) or with D-amphetamineInduced in the Striatum by Cocaine Could
sulfate (5 mg/kg, Sigma). The doses of 25 mg/kg cocaine and 5 mg/
Reflect Behaviorally Important Functional kg amphetamine were chosen on the basis of previous experiments
Changes in Basal Ganglia Circuits with acute treatment (Graybiel et al., 1990; Moratalla et al., 1992,
1993). The behavioral reactions of the animals were noted duringAlthough our findings only show a correlation between
the survival time.the pattern change in striatal gene expression and be-
havioral sensitization, they do raise the possibility that
the pattern change reflects neuroplasticity in the basal
Immunocytochemistry
ganglia contributing to the behavioral change. A striking Brains were fixed by transcardial perfusion with 4% paraformalde-
feature of the network-level change we found is that it hyde in 0.1 M sodium cacodylate buffer (pH 7.4), cryoprotected, and
cut transversely at 20 mm on a sliding microtome. In all, the brainsso closely parallels the time course of behavioral sensiti-
of 190 rats were analyzed.zation. To date, no other single neurological marker of
Single antigen immunostaining was performed on free-floatingpre- or postsynaptic function in the striatum has been
sections as described earlier (Graybiel et al., 1990), with a standardfound to parallel so fully the build-up and maintenance
avidin–biotin peroxidase (ABC) protocol (Vectastain, Vector Labora-
of sensitization during withdrawal from cocaine (see tories, Burlingame, CA). The peroxidase was detected with diamino-
Robinson and Becker, 1986; Kalivas and Stewart, 1991; benzidine (DAB, Sigma) with nickel intensification. Two-color dual
antigen immunostaining was obtained by serial ABC staining reac-Kalivas and Duffy, 1993). In our experiments, we found
tions with final steps in nickel-intensified DAB (purplish gray) andthis as well for the changes in inducibility of Fos–Jun
in DAB alone (brown). For NOS-containing interneurons, sectionsproteins and for the persistent expression of FRAs. The
were first immunostained by the ABC protocol and then reacted forinducibility and the expression of these proteins were
NADPH diaphorase activity histochemically (Xu et al., 1994).
dramatically altered, but the alterations lacked the com-
bination of early onset and prolonged maintenance
shown by behavioral sensitization. However, when we Antisera
To localize Fos–Jun family proteins, we used polyclonal rabbit anti-used the gene induction assay anatomically, as a way
sera against c-Fos (1:200, Oncogene Science,Manhasset, NY), JunBto identify which neurons were activated to express the
(1:4,000, provided by Dr. R. Bravo, Bristol-Myers, Princeton, NJ),genes on challenge, we found that a network-level shift
and the M peptide sequence shared by members of the Fos family
toward striosomal activation that did have the temporal (1:5,000, provided by Dr. M. I. Iadarola, National Institutes of Health,
characteristics of the behavioral change. Bethesda, MD). To localize striatal projection neurons, we used
antisera against dynorphin B 1–29 (1:10,000, provided by Dr. S.Behaviorists have suggested that the increased ste-
Watson, University of Michigan, Ann Arbor, MI), Met-enkephalinreotyped behavior exhibited by animals that become
(1:2,000, INCSTAR, Stillwater, MN), and calbindin D28K (1:3,000, pro-sensitized to psychomotor stimulants depends on the
vided by Dr. P. Emson, Medical Research Council, Brabaham, Unitedcaudoputamen (Robinson and Becker, 1986; Kalivas
Kingdom). To identify striatal interneurons, we used monoclonal
and Stewart, 1991). Our findings suggest that, within the mouse antiserum against parvalbumin (1:1,000, Sigma) and poly-
caudoputamen, an increased relative responsiveness of clonal goat antiserum against choline acetyltransferase (ChAT,
1:100, Chemicon, Temecula, CA).striosomal neurons to cocaine challenge emerges in the
Cocaine-Induced Network Changes in Fos–Jun Expression
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Western Immunoblotting alter striatal prodynorphin and zif/268 mRNAs. Mol. Brain Res. 29,
201–210.Striata were rapidly dissected from brains removed after decapita-
tion and sonicated in 10 vol of buffer (Hope et al., 1994). After Dilts, R.P., Helton, T.E., and McGinty, J.F. (1993). Selective induction
centrifugation, supernatant proteins were resolved by SDS– of Fos and Fra immunoreactivity within the mesolimbic and meso-
polyacrylamide gel electrophoresis and electroblotted onto nitrocel- striatal dopamine terminal fields. Synapse 13, 251–263.
lulose membranes (MSI, Westboro, MA). Membranes were incu-
Eblen, F., and Graybiel, A.M. (1995). Highly restricted origin of pre-bated with anti-FRA primary antiserum (1:4,000) (Young et al., 1991)
frontal cortical inputs to striosomes in the macaque monkey. J.and subsequently with HRP-conjugated goat anti-rabbit secondary
Neurosci. 15, 5999–6013.antibody (Bio-Rad, Richmond, CA, 1:4,000). Immunoreactivity was
Frank, D.A., and Greenberg, M.E. (1994). CREB: a mediator of long-detected by enhanced chemiluminescence (ECL, Amersham, Little
term memory from mollusks to mammals. Cell 79, 5–8.Chalfont, Buckinghamshire, United Kingdom).
Giros, B., Jaber, M., Jones, S.R., Wightman, R.M., and Caron, M.G.
(1996). Hyperlocomotion and indifference to cocaine and amphet-Image Analysis and Cell Counting
amine in mice lacking the dopamine transporter. Nature 379,Counting of immunopositive nuclei was done single-blind with a
606–612.103 objective with a Biocom imaging system (Les Ulis, France) at
a standard transverse level, z10 mm rostral to the interaural line. Graybiel, A.M. (1995). Building action repertoires: memory and learn-
A horizontal strip through the midheight of the caudoputamen was ing functions of the basal ganglia. Curr. Opin. Neurobiol. 5, 733–741.
chosen as the sample area for all sections. Before counting, the Graybiel, A.M., Moratalla, R., and Robertson, H.A. (1990). Amphet-
images were thresholded at a standardized gray-scale level empiri- amine and cocaine induce drug-specific activation of the c-fos gene
cally determined by independent observers to allow detection of in striosome–matrix and limbic subdivisions of the striatum. Proc.
nuclei stained with moderate to high intensity, with suppression of Natl. Acad. Sci. USA 87, 6912–6916.
lightly stained nuclei. The unprocessed color video image and the
Hope, B.T., Nye, H.E., Kelz, M.B., Self, D.W., Iadarola, M.J., Naka-microscope image were also viewed directly to resolve ambiguities.
beppu, Y., Duman, R.S., and Nestler, E.J. (1994). Induction of long-
lasting AP-1 complex composed of altered Fos-like proteins in brainAcknowledgments
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